Tetradecyltrimethylammonium-d38 (bromide)

[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])[2H].[Br-]

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Dopierala K, et al. The effect of molecular structure on the surface properties of selected quaternary ammonium salts. J Colloid Interface Sci. 2008;321 (1) :220-226.|[3]N. Gorski, et al. Mixtures of Nonionic and Ionic Surfactants. The Effect of Counterion Binding in Mixtures of Tetradecyldimethylamine Oxide and Tetradecyltrimethylammonium Bromide. Langmuir 1994, 10, 8, 2594-2603.|[4]Cocke DL, et al. The surface properties of tetradecyltrimethylammonium bromide observed by capillary electrophoresis. J Chromatogr Sci. 200240 (4) :187-190.